LGALS3

There are 80 papers on LGALS3 in aging research: 3 trials and 16 observational studies in people, 42 in animals, 5 in cells, 9 reviews. The newest story, Oct 2, 2026: “Lack of dietary DHA drives harmful lipid remodeling and retinal degeneration in mice”.

Gene

80 papers study it34 findings

HGNCMGINCBI GeneTaxon

1 new paper in 30 daysSee all 80 papers on LGALS3

At a glance

The findings reach people, from one lab or study. 16 independent labs in 7 countries.

“whose human plasma levels further demonstrated a strong association with all-cause mortality, disease incidence and risk factors, such as obesity and hypertension.”
Transcriptomic Hallmarks of Mortality Reveal Universal and Specific Mechanisms of Aging, Chronic Disease, and RejuvenationbioRxiv (Cold Spring Harbor Laboratory)2024doi:10.1101/2024.07.04.601982

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 16 independent labs in 7 countries
  • Funders: Agencia Nacional de Promoción Científica y Tecnológica and others
  • 2 of 33 findings with company ties
  • Human trial3
  • Humans16
  • Animals42
  • Cells5
  • In silico5

Interventions

3

Adenine base editor

downin human cells1

1 study
  1. Adenine base editor decreases LGALS3 in HGPS viECs after flow.

    “Treatment with an adenine base editor correcting the HGPS mutation restored LGALS3 expression to healthy levels.”

    Cellsin HGPS viECs after flowiPSC-derived endothelial cells24 h

    Hutchinson-Gilford progeria syndrome alters the endothelial genetic response to laminar shear stress

    Frontiers in physiology

More on Adenine base editor

Amalaki rasayana

downin rats1

1 study
  1. Amalaki rasayana inhibits LGALS3 in rat models of BA and PO-CH.

    “by inhibiting full-length galectin-3 secretion through phosphorylation-dependent mechanisms and promotion of intracellular retention”

    Animalsin rat models of BA and PO-CH

    Galectin-3 C-epitope, ANP, PPIA, and albumin function as drug-responsive panel biomarkers and therapeutic targets in aging and pressure overload-induced cardiac hypertrophy

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Amalaki rasayana

Lipopolysaccharide

upin mouse cells1

1 study
  1. Lipopolysaccharide increases LGALS3 in primary mouse microglial cells.

    “Using primary mouse microglial cells, galectin -3 was also increased by lipopolysaccharide treatment.”

    Cellsin primary mouse microglial cells

    Microglial galectin-3 increases with aging in the mouse hippocampus

    The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

More on Lipopolysaccharide

Effects

24

Retinal degeneration

upin mice1

1 study
  1. LGALS3 increases retinal degeneration in mice (later-stage degeneration under prolonged lipid burden; shown by deficiency).

    “Galectin-3 deficiency preferentially protected against later-stage degeneration, indicating that prolonged lipid burden converts the initial clearance response into a pathogenic response.”

    Animalslater-stage degeneration under prolonged lipid burden; shown by deficiency

    Lack of dietary DHA drives harmful lipid remodeling and retinal degeneration in mice

    bioRxivPreprint

Cartilage degeneration

upin human cells1

1 study
  1. LGALS3 increases cartilage degeneration in chondrocytes overexpressing LGALS3.

    “accelerated cartilage degeneration”

    Cellsin chondrocytes overexpressing LGALS3cartilage

    Mechanistic Insights into LGALS3-Mediated Osteoarthritis Progression: Activation of the cGAS-STING Pathway as a Key Driver of Senescence-Related Osteoarthritis

    Journal of Pharmaceutical Innovation

Mitochondrial function

downin human cells1

1 study
  1. LGALS3 impairs mitochondrial function in chondrocytes overexpressing LGALS3.

    “impaired mitochondrial function”

    Cellsin chondrocytes overexpressing LGALS3

    Mechanistic Insights into LGALS3-Mediated Osteoarthritis Progression: Activation of the cGAS-STING Pathway as a Key Driver of Senescence-Related Osteoarthritis

    Journal of Pharmaceutical Innovation

Cellular senescence

upin human cells1

1 study
  1. LGALS3 increases cellular senescence in chondrocytes overexpressing LGALS3.

    “promoted chondrocyte senescence (all p < 0.05)”

    Cellsin chondrocytes overexpressing LGALS3

    Mechanistic Insights into LGALS3-Mediated Osteoarthritis Progression: Activation of the cGAS-STING Pathway as a Key Driver of Senescence-Related Osteoarthritis

    Journal of Pharmaceutical Innovation

More on Cellular senescence

cGAS–STING signaling

upin human cells1

1 study
  1. LGALS3 activates cGAS–STING signaling in chondrocytes overexpressing LGALS3.

    “Functional experiments showed that LGALS3 overexpression activated the cGAS-STING pathway”

    Cellsin chondrocytes overexpressing LGALS3

    Mechanistic Insights into LGALS3-Mediated Osteoarthritis Progression: Activation of the cGAS-STING Pathway as a Key Driver of Senescence-Related Osteoarthritis

    Journal of Pharmaceutical Innovation

More on cGAS–STING signaling

NLRP3 inflammasome activation

upin mouse cells1

1 study
  1. LGALS3 increases NLRP3 inflammasome activation in mouse cells (via direct binding to TLR4 on macrophages).

    “This cell communication facilitates the progression of silicosis by promoting fibroblast-myofibroblast transition (FMT) and NLRP3 inflammasome activation.”

    Cellsvia direct binding to TLR4 on macrophagesmacrophages

    Senescent endothelial cell-derived Galectin 3 promotes silicosis through endothelial-fibroblast and endothelial-macrophage crosstalk

    Journal of hazardous materials

fibroblast-myofibroblast transition

upin mouse cells1

1 study
  1. LGALS3 increases fibroblast-myofibroblast transition in mouse cells (via direct binding to TGFBR1 on lung fibroblasts).

    “This cell communication facilitates the progression of silicosis by promoting fibroblast-myofibroblast transition (FMT) and NLRP3 inflammasome activation.”

    Cellsvia direct binding to TGFBR1 on lung fibroblastslung fibroblasts

    Senescent endothelial cell-derived Galectin 3 promotes silicosis through endothelial-fibroblast and endothelial-macrophage crosstalk

    Journal of hazardous materials

Microglial engulfment

upin cells1

1 study
  1. LGALS3 increases microglial engulfment in cells following EDP incubation.

    “Following EDP incubation, galectin 3 (Gal-3) released by neurons served as a chemokine, attracting microglial engulfment.”

    Cellsfollowing EDP incubation

    Accumulation of extracellular elastin-derived peptides disturbed neuronal morphology and neuron-microglia crosstalk in aged brain

    Journal of neurochemistry

Neurodegeneration

upin mice1

1 study
  1. LGALS3 increases neurodegeneration in mice (shown by knockout (Gal3-/-)).

    “OxPC-mediated neurodegeneration was reduced in Gal3-/- mice compared with Gal3+/+ mice”

    Animalsshown by knockout (Gal3-/-)spinal cord white matter

    Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration

    The Journal of neuroscience : the official journal of the Society for Neuroscience

Cognitive function

downin mice1

1 study
  1. LGALS3 impairs cognitive function in mice (Shown by hippocampal knockdown in LPS-challenged aged mice).

    “hippocampal Gal-3 knockdown attenuated neuroinflammation and neuronal apoptosis in the hippocampus of LPS-challenged aged mice, and this was associated with improved cognitive function.”

    AnimalsShown by hippocampal knockdown in LPS-challenged aged mice

    Hippocampal Galectin-3 knockdown alleviates lipopolysaccharide-induced neurotoxicity and cognitive deficits by inhibiting TLR4/NF-кB signaling in aged mice

    European journal of pharmacology

All 24

Upstream

3

FLI1

downin human cells1

1 study
  1. FLI1 decreases LGALS3 in human cells (shown by Fli1 loss in macrophages).

    “Fli1 loss derepressed the LGALS3 promoter, increasing Gal-3 in macrophages”

    Cellsshown by Fli1 loss in macrophagesmacrophage

    Down-Regulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis Via a Galectin-3/mTOR Dependent Pathway

    Arthritis & rheumatology (Hoboken, N.J.)

More on FLI1

Progeria

upin human cells1

1 study
  1. Progeria increases LGALS3 in human cells after flow.

    “RT-PCR confirmed LGALS3 is robustly upregulated in HGPS viECs compared with healthy viECs after flow.”

    Cellsafter flowiPSC-derived endothelial cells24 h

    Hutchinson-Gilford progeria syndrome alters the endothelial genetic response to laminar shear stress

    Frontiers in physiology

More on Progeria

Age-related hearing loss

upin silico1

1 study
  1. Age-related hearing loss increases LGALS3 in silico (age-related hearing loss).

    “Validation in five independent transcriptomic datasets (GSE49543, GSE6045, GSE153882, GSE154833, and GSE233798) confirmed their upregulation in ARHL samples”

    In silicoage-related hearing losscochlea

    Integrative multi-dataset analysis identifies immune-inflammatory hub genes as diagnostic biomarkers and therapeutic targets for age-related hearing loss

    Hearing research

More on Age-related hearing loss

Associations

4

Systolic blood pressure

upin humans1

1 study
  1. LGALS3 is associated with systolic blood pressure in humans (β=4.06).

    “whereas LGALS3 showed a weaker positive association (β=4.06; P=0.019).”

    Humanswhole blood

    Whole-Blood Transcriptomics Highlights Galectin-1 in Systolic Blood Pressure

    bioRxiv : the preprint server for biologyPreprint

Osteoarthritis

upin humans1

1 study
  1. LGALS3 is associated with osteoarthritis in humans (OA chondrocytes versus healthy controls, RNA-seq from GEO).

    “LGALS3 expression was significantly elevated in OA chondrocytes.”

    HumansOA chondrocytes versus healthy controls, RNA-seq from GEOchondrocytes

    Mechanistic Insights into LGALS3-Mediated Osteoarthritis Progression: Activation of the cGAS-STING Pathway as a Key Driver of Senescence-Related Osteoarthritis

    Journal of Pharmaceutical Innovation

More on Osteoarthritis

Mortality

upin humans1

1 study
  1. LGALS3 is associated with mortality in humans (human plasma levels).

    “whose human plasma levels further demonstrated a strong association with all-cause mortality, disease incidence and risk factors, such as obesity and hypertension.”

    Humanshuman plasma levels

    Transcriptomic Hallmarks of Mortality Reveal Universal and Specific Mechanisms of Aging, Chronic Disease, and Rejuvenation

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Frailty

mixedin humans1

1 study
  1. LGALS3 is associated with frailty in humans (overlap between frailty-related and aging-related differentially expressed genes in PBMCs).

    “LGALS3 was identified as the overlapping gene between frailty-related DEGs and aging-related DEGs.”

    Humansoverlap between frailty-related and aging-related differentially expressed genes in PBMCsperipheral blood mononuclear cells

    High blood galectin-3 level associated with risk of frailty in aging

    Frontiers in endocrinology

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 3Mar 2026: 2Apr 2026: 2May 2026: 4Jun 2026: 3Jul 2026: 1Aug 2026: 2Sep 2026: 5Oct 2026: 1Nov 2026: 026 papers in 12 months
Research Square

Compound reduced disease-linked aging-like gene changes in mice

In mice with chemically induced Gaucher disease, MA-5 reduced aging-like gene changes, with particularly prominent effects in brain immune cells.In mice with chemically induced Gaucher disease, MA-5 reduced aging-like gene changes, with particularly prominent effects in brain immune cells.

Preprint: mouse studyInterventions

See all 80 papers on LGALS3